Safety and efficacy of duloxetine treatment in older and younger patients with osteoarthritis knee pain: A post hoc, subgroup analysis of two randomized, placebo-controlled trials

BMC Musculoskeletal Disorders

Volumn 14, Issue , 2013, Pages

  Micca, Joseph L ^a   Ruff, Dustin ^b   Ahl, Jonna ^b   Wohlreich, Madelaine M ^b  

^a Patient Centered Healthcare   (United States)

^b Lilly USA   (United States)

Author keywords

Duloxetine; Older patients; Osteoarthritis of the knee; Pain

Indexed keywords

DULOXETINE; PLACEBO; ANALGESIC AGENT; THIOPHENE DERIVATIVE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL PRACTICE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; KNEE PAIN; MALE; NAUSEA; POST HOC ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; TREATMENT DURATION; AGE; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECTS; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN; PAIN MEASUREMENT; PROCEDURES; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALGESICS; DIZZINESS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN; PAIN MEASUREMENT; THIOPHENES; TREATMENT OUTCOME;

EID: 84876095999     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-14-137     Document Type: Article

References (21)

1. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Lawrence RC, Helmick CG, Arnett FC, Felson DT, Giannini EH, Heyse SP, Hirsch R, Hochberg MC, Hunder GG, Liang MH, Pillemer ST, Steen VD, Wolf F, Arthritis Rheum 1998 41 778 799 10.1002/1529-0131(199805)41: 5<778::AID-ART4>3.0.CO;2-V 9588729
2. Investigating the relationship between pain and discomfort and quality of life, using the WHO-QOL. Skevington SM, Pain 1998 76 395 406 10.1016/S0304-3959(98)00072-4 9718258
3. Management of knee osteoarthritis in primary care: pain and depression are the major obstacles. Axford J, Heron C, Ross F, Victor CR, J Psychosom Res 2008 64 461 467 10.1016/j.jpsychores.2007.11.009 18440398
4. Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Bair MJ, Wu J, Damush TM, Sutherland JM, Kroenke K, Psychosom Med 2008 70 8 890 897 10.1097/PSY. 0b013e318185c510 18799425
5. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P, Osteoarthr Cartilage 2008 16 137 162 10.1016/j.joca.2007.12.013
6. Pharmacological management of persistent pain in older patients. Fine PG, Clin J Pain 2004 20 220 226 10.1097/00002508-200407000-00003 15218406
7. Management of chronic arthritis pain in the elderly. Fitzcharles MA, Lussier D, Shir Y, Drugs Aging 2010 27 471 490 10.2165/11536530-000000000-00000 20524707
8. Pharmacological management of persistent pain in older persons. Ickowicz E, J Am Geriatr Soc 2009 57 1331 1346 19573219
9. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Raskin J, Pritchett YL, Wang F, D'Souza DN, Waninger AL, Iyengar S, Wernicke JF, Pain Med 2005 6 346 356 10.1111/j.1526-4637.2005.00061.x 16266355
10. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Wernicke JF, Pritchett YL, D'Souza DN, Waninger A, Tran P, Iyengar S, Raskin J, Neurology 2006 67 1411 1420 10.1212/01.wnl.0000240225. 04000.1a 17060567
11. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ, Arthritis Rheum 2004 50 2974 2984 10.1002/art.20485 15457467
12. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Russell JI, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM, Detke MJ, Walker DJ, Chappell AS, Arnold LM, Pain 2008 136 432 444 10.1016/j.pain.2008.02.024 18395345
13. A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain. Skljarevski V, Ossanna MJ, Liu-Seifert H, Zhang Q, Chappell A, Iyengar S, Detke M, Backonja M, Eur J Neurol 2009 16 1041 1048 10.1111/j.1468-1331.2009.02648.x 19469829
14. Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed dose, randomized, double-blind trial. Skljarevski V, Zhang S, Desaiah D, Alaka KJ, Palacios S, Miazgowski T, Patrick K, J Pain 2010 11 12 1282 1290 10.1016/j.jpain.2010.03.002 20472510
15. Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial. Chappell AS, Ossanna MJ, Liu-Seifert H, Iyengar S, Skljarevski V, Li LC, Bennett RM, Collins H, Pain 2009 146 253 260 10.1016/j.pain.2009.06.024 19625125
16. A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment chronic pain due to osteoarthritis of the knee. Chappell AS, Desaiah D, Liu-Seifert H, Zhang S, Skljarevski V, Belenkov Y, Brown JP, Pain Pract 2011 11 1 33 41 10.1111/j.1533-2500.2010.00401.x 20602715
17. Duloxetine for the management of pain in older adults with knee osteoarthritis: randomised placebo-controlled trial. Abou-Raya S, Abou-Raya A, Helmi M, Age Aging 2012 41 5 646 652 10.1093/ageing/afs072
18. Pain assessment: global use of the brief inventory. Cleeland CS, Ryan KM, Ann Acad Med Singapore 1994 23 129 138 8080219
19. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Herqueta T, Baker R, Dunbar GC, J Clin Psychiatry 1998 59 Suppl 20 22 33 9881538
20. Safety and efficacy of duloxetine in the treatment of diabetic peripheral neuropathic pain in older patients. Wasan AD, Ossanna MJ, Raskin J, Wernicke JF, Robinson MJ, Hall JA, Edwards SE, Lipsius S, Meyers AL, McCarberg BH, Curr Drug Saf 2009 4 22 29 10.2174/157488609787354404 19149522
21. Statistics in medicine-reporting of subgroup analyses in clinical trials. Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM, N Engl J Med 2007 357 2189 2194 10.1056/NEJMsr077003 18032770